ETHZilla Corporation Common Stock (ATNF) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Palo Alto, CA, 美国. 现任CEO为 Lloyd Blair Jordan.
ATNF 拥有 IPO日期为 2017-06-27, 4 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.08B.
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
